Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Wednesday, October 7, 2026

Medial gastrocnemius muscle and tendon morphology in first-ever chronic stroke survivors using three-dimensional freehand ultrasound: a cross-sectional reliability and validity study

 Not telling us RECOVERY RESULTS is incompetence! 'Assessments' have never gotten anyone recovered!

“What's measured, improves.” So said management legend and author Peter F. Drucker !   
If you don't measure it, you can't improve it and make it repeatable! 
The latest crapola here:

Medial gastrocnemius muscle and tendon morphology in first-ever chronic stroke survivors using three-dimensional freehand ultrasound: a cross-sectional reliability and validity study

    We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.

    Abstract

    Background

    Morphological muscle–tendon (MMT) adaptations occur after stroke but remain insufficiently characterized because objective, clinically applicable assessment methods are limited. Three-dimensional freehand ultrasound (3DfUS) offers a promising approach for the simultaneous assessment of muscle–tendon morphology.

    Methods

    This study aimed to (1) assess the repeatability of three-dimensional freehand ultrasound (3DfUS) for measuring GM MMT properties and (2) compare GM muscle length, tendon length, and muscle thickness between 35 first-ever chronic stroke survivors and 23 healthy controls. 3DfUS was used to assess GM MMT properties. Inter-/intra-operator as well as inter- and intra-processor repeatability were evaluated using intraclass correlation coefficients (ICC), standard error of measurement (SEM), minimum detectable change (MDC), and Bland–Altman analysis. Group comparisons were performed using Wilcoxon signed-rank and Mann–Whitney U tests.

    Results

    Inter- and intra-operator as well as inter- and intra-processor repeatability demonstrated ICC values ranging from 0.84 to 0.999, indicating good to excellent repeatability across all evaluated MMT parameters. Stroke survivors demonstrated significantly lower normalized muscle thickness in both the affected (P = 0.005) and non-affected (P < 0.001) limbs compared with healthy controls, whereas no significant differences were observed for normalized muscle belly length or tendon length.

    Conclusion

    3DfUS is a reliable method for the objective assessment(Assessments don't tell us recovery, do they?) of GM muscle–tendon morphology after stroke. The observed bilateral reduction in GM nMT indicates that structural muscle changes after stroke are not restricted to the affected limb. Furthermore, this study demonstrates the feasibility of simultaneously quantifying multiple clinically relevant MMT parameters using 3DfUS. Together, these findings provide preliminary evidence of the ability of 3DfUS to discriminate between chronic stroke survivors and healthy controls and warrant further evaluation in research and clinical practice.

    Trial registration ClinicalTrials.gov ID NCT04607486.

    No comments:

    Post a Comment